Latest / EMJ Podcast: Insights For Healthcare Professionals
AMJ Podcast | Episode 8 | Real-World Insights into Biologic Initiation and Adherence in Severe Asthma Inside
This podcast was developed by AMJ in collaboration with GSK and is sponsored by GSK. This information is scientific and non-promotional in nature, and intended for US audiences.
Less than 20% of biologic-eligible patients with GINA Step 5 asthma receive biologic therapy.1,2 In this AMJ podcast, experts discuss how real-world gaps in initiation, access, and adherence can affect whether patients start, stay on, and sustain benefit from biologic therapy over time.
Listen to the full episode to explore:
Key real-world data on biologic initiation and adherence in severe asthma
Patient cases…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.